文献速递中医内科中药与中成药合理使用

中药注射剂治疗社区获得性肺炎疗效的贝叶斯网络Meta分析

Comparative efficacy of Chinese herbal injections for the treatment of community-acquired pneumonia: A Bayesian network meta-analysis of randomized controlled trials.
PubMed 文献 · Phytomedicine · 2019-07-02

本研究通过贝叶斯网络Meta分析比较热毒宁(RDN)、炎琥宁(YHN)、喜炎平(XYP)和痰热清(TRQ)四种中药注射剂联合西药与单用西药治疗社区获得性肺炎(CAP)的疗效。共纳入47项随机对照试验、4713例患者。结果显示四种中药注射剂联合西药均显著改善治疗表现,其中YHN+WM在临床有效率等方面较优,TRQ+WM在退热和住院时间上最优,XYP+WM在肺啰音消失时间上最优,但安全性证据尚不充分。

要点

  • 中药注射剂联合西药较单用西药可改善CAP治疗表现。
  • YHN+WM在临床有效率、咳嗽消失时间和CRP水平上优势明显。
  • TRQ+WM缩短退热时间和住院时间最优,XYP+WM减少肺啰音时间最优。

核心结论

  • 中药注射剂联合西药治疗CAP较单用西药可改善治疗表现并使患者受益。
  • 综合临床有效率等结局,YHN+WM对CAP患者的改善可能更优。
  • 安全性方面尚需更多证据支持。

研究设计与样本

  • 贝叶斯网络Meta分析,检索多个数据库自建库至2018年6月。
  • 纳入47项随机对照试验,共4713例患者,涉及4种中药注射剂。
  • 采用Cochrane偏倚风险工具和改良Jadad量表评估质量,STATA 13.0和WinBUGS 14.0分析。
  • 使用SUCRA概率值排序,并采用聚类分析比较两种结局的效果。

主要发现

  • RDN、YHN、XYP和TRQ联合WM均较单用WM显著改善治疗表现。
  • YHN+WM在临床有效率、咳嗽消失时间和C反应蛋白水平上具有明显优势。
  • TRQ+WM在缩短退热时间和平均住院时间上最具优势。
  • XYP+WM在缩短肺啰音消失时间上表现最佳。

关键数值与推荐

  • 共纳入47项随机对照试验,涉及4713例患者和4种中药注射剂。
  • 检索时间范围为建库至2018年6月。

临床怎么用

  • 对于CAP患者,可考虑在常规西药治疗基础上联合中药注射剂以改善治疗表现。
  • 若综合临床有效率等结局,YHN+WM可能为优先选择。
  • 若需缩短退热和住院时间,可考虑TRQ+WM;若需促进肺啰音消失,可考虑XYP+WM。
  • 使用中药注射剂时需关注安全性,现有证据尚不充分。

局限性

  • 安全性结论证据不足,需更多研究支持。
  • 纳入研究的方法学质量可能影响结果可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Considering the limitations of conventional western treatment for community-acquired pneumonia (CAP) and the extensive exploration of Chinese herbal injections (CHIs), systematically and critically evaluating the efficacy of CHIs in the treatment of CAP is necessary. PURPOSE: This study constructed a network meta-analysis (NMA) to investigate the efficacy of CHIs (including the Reduning injection (RDN), Yanhuning injection (YHN), Xiyanping injection (XYP), and Tanreqing injection (TRQ)) combined with Western medicine (WM) and WM alone in CAP. METHODS: A literature review was conducted in several databases from inception to June 2018. The quality of the included studies was assessed by the Cochrane risk of bias tool and modified Jadad scale. Data were analyzed by STATA 13.0 and WinBUGS 14.0 software. Surface under the cumulative ranking curve (SUCRA) probability values were applied to rank the examined treatments. Clustering analysis was utilized to compare the effect of CHIs between two different outcomes. RESULTS: A total of 47 eligible randomized controlled trials involving 4713 patients and 4 CHIs were included. The results of the NMA showed that RDN, YHN, XYP and TRQ combined with WM significantly improved treatment performance compared to WM alone. YHN+WM had obvious superiorities in the clinical effective rate, time for the disappearance of cough and the level of C-reactive protein. TRQ+WM was the most advantageous in shortening the time for defervescence and the average hospitalization time. XYP+WM was shown to reduce the time for the disappearance of lung rales best. Sixteen articles reported adverse drug reactions/adverse drug events (ADRs/ADEs) in detail, and 17 articles reported that there were no obvious ADRs/ADEs. CONCLUSION: This NMA showed that using CHIs in combination with WM improved treatment performance and could be beneficial for patients with CAP compared to using WM alone. Thereinto, YHN+WM showed a preferable improvement on patients with CAP when unified considering the clinical effective rate and other outcomes. As for safety, more evidence is needed to support this hypothesis.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Huang X, Duan X, Zhu Y, et al. Comparative efficacy of Chinese herbal injections for the treatment of community-acquired pneumonia: A Bayesian network meta-analysis of randomized controlled trials. Phytomedicine. 2019. PMID: 31301540. doi:10.1016/j.phymed.2019.153009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。